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Abstract
Vibrio spp. is a pathogen rarely isolated in cancer patients, and in most cases it is associated with
haematological diseases. Cutaneous manifestations of this organism are even rarer. We report a
case of Non-O1 Vibrio cholerae inguinal skin and soft tissue infection presenting bullous skin lesions
in a young type II diabetic patient with a penis squamous cell carcinoma having a seawater exposure
history.
Introduction
Vibrio cholerae is mainly related to water sources [1]. Con-
taminated seawater exposure or contaminated seafood
ingestion are frequently associated with diarrhoea and/or
extraintestinal infections such as otitis media, skin and
soft tissue infections (SSTI) and bacteremia [1,2]. Vibrio
spp. is a pathogen rarely isolated in cancer patients, and in
most cases it is associated with haematological diseases.
Although the clinical picture may have a wide range in
Vibrio spp. SSTI, bullous lesions are almost exclusively
associated with V. vulnificus infection [3,4] and have rarely
been reported with non-O1 V. cholerae infections [4,5].
We report here the case of a non-O1 V. cholerae SSTI pre-
senting bullous skin lesions in a diabetic patient with a
solid tumour.
Case report
A 36-year-old patient from the Canary Islands (Spain)
with controlled type II diabetes mellitus was diagnosed
with a moderately differentiated squamous cell carcinoma
of the penis in December 2006 in his local hospital. The
patient underwent a partial penectomy. In the initial fol-
low-up after surgery, the abdominal CT and granulation
tissue were normal. The patient had been exposed to sea-
water and seafood from December 2006 to October 2007
when bullous skin lesions were observed in both inguinal
regions during a examination. Lesions were fitted with
inguinal metastases, and the patient underwent inguinal
surgery followed by radiotherapy.
In November 2007 he was admitted to our hospital for a
second consultation. Physical examination showed stink-
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bullae. Patient underwent an abdominal computed tom-
ography (CT) scan with contrast that revealed the exist-
ence of several large necrotic adenopathies in the
inguinal, scrotal and pubic areas (Figure 1). A right
abdominal wall nodule and a left groin abscess extending
from psoas muscle to skin were also observed. A CT scan
of the chest showed pulmonary lesions compatible with
metastases. Initial laboratory findings showed increased a
white blood cell count of 20,3 × 109/L with 88,1% neu-
trophils, haemoglobin of 8,3 g/dL and a C-reactive pro-
tein of 8,7 mg/dL (normal range 0–1 mg/dL).
The patient was treated with a left inguinal region debri-
dement, percutaneous drainage and flamazine therapy.
Purulent fluid was obtained by swabbing from the fistu-
lized left bulla and was sent for culture (Figure 2). At that
time, two sets of blood cultures were drawn. Empiric
intravenous antimicrobial therapy with ceftriaxone 1 g/24
h and metronidazole 500 mg/8 h was started. Daily cures
with Flamazine were also indicated. A Gram stain of the
sample showed abundant polymorphonuclear leuko-
cytes, and cultures yielded Escherichia coli, Serratia marces-
cens and V. cholerae susceptible to the empiric
antimicrobial therapy instituted. Blood cultures were ster-
ile after incubation for six days. As the patient was not
improving after 7 days of therapy, a new sample was taken
with a syringe. Methicillin-susceptible Staphylococcus
aureus and the same E. coli, characterized by phenotypic
methods (biotype and antimicrobial susceptibility) were
isolated. Those microorganisms were carbapenems-sus-
ceptible so the antibiotic therapy was switched to ertap-
enem 1 g/24 h i.v. and cellulitis gradually improved.
A new sample was taken for control with a syringe from
the left inguinal lesion after 2 weeks of treatment with
ertapenem. Enriched alkaline peptone water (1% NaCl
pH 8.5) and TCBS agar were added to the conventional
media plates and only V. cholerae was again isolated. The
therapy was changed to oral levofloxacin 500 mg/12 h.
After one month of treatment with levofloxacin a new
sample for control from the left inguinal lesion was taken
with a syringe, resulting sterile after incubation for a week
in selective media. Thus, the levofloxacin dosage was
switched to oral levofloxacin 500 mg/24 h. After 40 days
with levofloxacin 500 mg/24 h, the right bulla fistulized,
so a new debridement and percutaneous drainage was
done in order to eliminate the necrotic tissue. New sam-
ples of both inguinal regions were obtained by means of
syringe and were found sterile after 7 days of incubation
in selective media.
During this time, the patient was treated with two cycles
of first- and second-line palliative chemotherapy and one
cycle of third-line palliative chemotherapy. Due to the
metastasis progression, it was decided to stop the chemo-
therapy. In March, the patient returned to the Canary
Islands under treatment with oral levofloxacin 500 mg/24
h. The patient died two weeks later due to his underlying
disease.
V. cholerae is a curved Gram-negative rod that grows as beta-
hemolytic mucous colonies on blood agar plates and yel-
low colonies on thiosulfate-citrate-bile salts-sucrose
(TCBS) agar plates. V. cholerae was identified by two com-
mercial identification systems: VITEK 2 (bioMérieux® SA,
Marcy-L'Etoile, France) and API 20E Enterobacteriaceae
(bioMérieux®, France). It was susceptible to the O/129
vibriostatic agent (Oxoid, Ltd., Basingstoke, UK), and slide
agglutination tests with polyvalent antisera showed a non-
O1, non-O139 serotype. Antibiotic susceptibility testing
was performed by standard disk diffusion method on
Mueller-Hinton agar, and minimal inhibition concentra-
tions (MICs) were determined by the Etest® diffusion
Several large necrotic adenopathies in inguinal, scrotal and pubic area (CT scan)Figu e 1
Several large necrotic adenopathies in inguinal, scro-
tal and pubic area (CT scan).
Skin lesions and cellulitis after a mayor cureFigure 2
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guidelines interpretative criteria for Vibrio spp. [6] the strain
was susceptible to ampicillin (8 μg/ml), amoxicillin-clavu-
lanic (4 μg/ml), ceftriaxone (0.016 μg/ml), ceftazidime
(0.25 μg/ml), gentamicin (1 μg/ml), tobramycin (4 μg/ml),
amikacin (8 μg/ml), ciprofloxacin (0.004 μg/ml), levo-
floxacin (0.008 μg/ml), piperacillin-tazobactam (0.38 μg/
ml), chloramphenicol (8 μg/ml), trimethoprim-sulfameth-
oxazole (0.125 μg/ml) and doxycycline (2 μg/ml). The
sample was sent to the National Center for Microbiology
(Majadahonda, Madrid, Spain) and was confirmed to be
non-O1 V. cholerae non-producer of toxin. The gene sodB
for the identification of V. cholerae was detected. Neither
the genes wbeO and rfb for the O1 and O139 serotype iden-
tification, nor the gene ctxA encoding cholera toxin were
detected by multiplex PCR technique.
Discussion
SSTI are often deep and devastating [7]. Etiology may be
mono or polymicrobial involving a mixed aerobe-anaer-
obe bacterial flora [7]. Although this case involved a
necrotizing skin and soft-tissue infection with polymicro-
bial etiology repeated V. cholerae isolates suggested V. chol-
erae was likely a major player in this patient's infection.
Vibrio spp. SSTI may range from bullous skin lesions and
localised cellulitis to severe necrotizing soft-tissue infec-
tion with secondary septicaemia [8,9]. V. vulnificus fol-
lowed by V. parahaemolyticus and V. alginolyticus are the
species most commonly isolated from wounds whereas
non-O1 V. cholerae is the less common involved species
[3,10]. Although bullous lesions occur mainly in patients
with V. vulnificus, infection, bullae in non-O1 V. cholerae
infection have been rarely reported [4,5].
Vibrio spp. infections are rarely documented in cancer
patients and they are infrequent in solid tumours [11].
Cellulitis due to non-O1 V. cholerae is rare and it is nor-
mally associated with the presence of chronic underlying
diseases such as liver cirrhosis, diabetes mellitus, immu-
nocompromised states or haematological malignancies
such as chronic lymphocytic leukaemia, acute myeloid or
lymphoblastic leukaemia and multiple myeloma or lym-
phocytic lymphoma [2,4,5,11-17].
To the best of our knowledge, only 13 cases of non-O1 V.
cholerae extraintestinal infections in immunocompro-
mised patients have been reported since 1978 (Table 1).
Only one case had a documented cellulitis [12]. Patients
were largely male (10 cases) with a mean age of 61 years
(range, 36–78 years). Risk factors for Vibrio spp. infection
were found in ten cases; 8 of them had liver disease. Inter-
estingly, 10 patients had a solid tumour and only 3
patients had a hematological disease. Twelve cases pre-
sented fever, bacteremia or diarrhoea. Nine patients sur-
vived. The remaining patients died from V. cholerae
infections or from underlying diseases. Our case is
remarkable because it represents the second reported case
of bullous lesions and cellulitis associated with non O1-
V. cholerae in a cancer patient.
Table 1: Clinical summary of 14 published cases of non-O1 V. cholerae extraintestinal infections in immunocompromised patients.
Age (years)/gender Clinical syndrome Risk factors other than neoplasia Underlying condition Outcome Reference
72/m Fever
Bacteremia
Renal insufficiency MM Recovered [13]
51/m Pneumonia, diarrhoea - CLL Expired [14]
59/m Bacteremia Cirrhosis Hepatoma Recovered [1]
69/m Ascites Cirrhosis Hepatoma Expired [1]
50/m Bacteremia Cirrhosis Hepatoma Recovered [1]
54/m Bacteremia Cirrhosis Hepatoma Recovered [1]
60/f Diarrhoea Cirrhosis Hepatoma Recovered [15]
36/m Bacteremia Cirrhosis Hepatoma Expired [15]
78/m Fever
Bacteremia
- NSCLC Recovered [11]
62/m Cachexia
Fever
Liver insufficiency GC Recovered [16]
77/m Fever
Splenic abscess
Diabetes PC Expired [17]
78/f Ascites
Bacteremia
Chronic liver disease CC Recovered [12]
54/f Bacteremia
Cellulitis
No ML Expired [5]
36/m Cellulitis Diabetes SCPC Expired Reported case
MM, multiple myeloma; CLL, chronic lymphocytic leukemia; NSCLC, non-small-cell lung carcinoma; GC, gastric cancer; PC pancreatic cancer; CC, 
cervix carcinoma; ML, myeloid leukemia; SCPC, squamous-cell penis carcinoma.Page 3 of 4
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The case reported shows that non O1-V. cholerae may pro-
duce wound infections in cancer patients with infrequent
clinical manifestations. In conventional mediums Vibrio
spp. can easily remain undetected especially when pol-
ymicrobial infections occur. Consequently, Vibrio spp.
should be considered in the differential diagnosis of any
SSTI in immunocompromised patients, principally those
occurring after seafood ingestion or contact with salt or
estuary water. Thus, in these cases, physicians should alert
the microbiology laboratory to add selective and enriched
culture mediums in addition to routine media.
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